Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Open accessAbstract
The accumulation of misfolded alpha-synuclein (aSyn) throughout the brain, as Lewy pathology, is a phenomenon central to Parkinson’s disease (PD) pathogenesis. The stereotypical distribution and evolution of the pathology during disease is often attributed to the cell-to-cell transmission of aSyn between interconnected brain regions. The spreading of conformationally distinct aSyn protein assemblies, commonly referred as strains, is thought to result in a variety of clinically and pathologically heterogenous diseases known as synucleinopathies. Although tremendous progress has been made in the field, the mechanisms involved in the transfer of these assemblies between interconnected neural networks and their role in driving PD progression are still unclear. Here, we present an update of the relevant discoveries supporting or challenging the prion-like spreading hypothesis. We also discuss the importance of aSyn strains in pathology progression and the various putative molecular mechanisms involved in cell-to-cell protein release. Understanding the pathways underlying aSyn propagation will contribute to determining the etiology of PD and related synucleinopathies but also assist in the development of new therapeutic strategies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
α-syn aggregation results in a gain of toxic function.
“However, its aggregation results in a gain of toxic function.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [205]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415 · see citing works
Novel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,121 · see citing works
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622 · see citing works
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737 · see citing works
Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,684 · see citing works
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029 · see citing works
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · see citing works
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,975 · see citing works
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 1,906 · see citing works
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845 · see citing works
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V. L., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,817 · see citing works
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · see citing works
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722 · see citing works
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683 · see citing works
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569 · see citing works
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P., Boyer, L. F., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,494 · see citing works
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · see citing works
Colombo, M., Moita, C. F., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Théry, C., & Raposo, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.128868 · Cited by 1,472 · see citing works
Kim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397 · see citing works
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354 · see citing works
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Bartels, T., Choi, J. G., & Selkoe, D. J. (2011) · Nature · doi:10.1038/nature10324 · Cited by 1,263 · cited 1× · see citing works
“Intriguingly, under physiological conditions, aSyn was also described to exist as helically folded tetramers that might be more resistant to aggregation, but these findings remain controversial [39].”
Backgroundα-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130 · see citing works
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127 · see citing works
Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · see citing works
Luk, K. C., Kehm, V. M., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M. ‐. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112457 · Cited by 1,087 · see citing works
Giasson, B. I., Murray, I. V. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008919200 · Cited by 1,080 · see citing works
A General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,058 · see citing works
Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,026 · see citing works
Structure and Dynamics of Micelle-bound Human α-Synuclein
Ulmer, T. S., Bax, A., Cole, N. B., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411805200 · Cited by 966 · see citing works
Luk, K. C., Song, C., O’Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 957 · see citing works
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1343-6 · Cited by 925 · see citing works
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911 · see citing works
Kayed, R., Sokolov, Y., Edmonds, B. W., McIntire, T. M., Milton, S. C. F., Hall, J. E., & Glabe, C. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400260200 · Cited by 903 · see citing works
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, Á., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 901 · see citing works
α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Wong, Y. C., & Krainc, D. (2017) · Nature Medicine · doi:10.1038/nm.4269 · Cited by 897 · see citing works
Exosomes are released by cultured cortical neurones
Fauré, J., Lachenal, G., Court, M., Hirrlinger, J., Chatellard-Causse, C., Blot, B., Grange, J., Schoehn, G., Goldberg, Y., Boyer, V., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.12.003 · Cited by 896 · see citing works
Structural and functional characterization of two alpha-synuclein strains
Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Oliéric, V., Böckmann, A., Meier, B. H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3575 · Cited by 890 · see citing works
Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842 · see citing works
Self-citationDiscriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
Shahnawaz, M., Mukherjee, A., Pritzkow, S., Mendez, N., Rabadia, P., Liu, X., Hu, B., Schmeichel, A., Singer, W., Wu, G., et al. (2020) · Nature · doi:10.1038/s41586-020-1984-7 · Cited by 820 · see citing works
Vagotomy and subsequent risk of <scp>P</scp> arkinson's disease
Svensson, E., Horváth‐Puhó, E., Thomsen, R. W., Djurhuus, J. C., Pedersen, L., Borghammer, P., & Sørensen, H. T. (2015) · Annals of Neurology · doi:10.1002/ana.24448 · Cited by 806 · see citing works
Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates
Lee, H.-J., Patel, S. S., & Lee, S. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0692-05.2005 · Cited by 798 · see citing works
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790 · see citing works
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 779 · see citing works
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 767 · see citing works
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez‐Erviti, L., Seow, Y., Schapira, A. H. V., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. A. D. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 741 · see citing works
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Mao, X., Ou, M. T., Karuppagounder, S. S., Kam, T., Yin, X., Xiong, Y., Ge, P., Umanah, G. K. E., Brahmachari, S., Shin, J., et al. (2016) · Science · doi:10.1126/science.aah3374 · Cited by 739 · see citing works
Olfactory dysfunction in Parkinson disease
Doty, R. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.80 · Cited by 737 · see citing works
El‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715 · see citing works
Braak, H., Tredici, K. D., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 710 · see citing works
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680 · see citing works
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
Prusiner, S. B., Woerman, A. L., Mordes, D. A., Watts, J. C., Rampersaud, R., Berry, D. B., Patel, S. S., Oehler, A., Lowe, J. K., Kravitz, S. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514475112 · Cited by 679 · see citing works
Buell, A. K., Galvagnion, C., Gaspar, R., Sparr, E., Vendruscolo, M., Knowles, T. P. J., Linse, S. S., & Dobson, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315346111 · Cited by 666 · see citing works
α-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J., & Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 656 · see citing works
Recasens, A., Dehay, B., Bové, J., Carballo‐Carbajal, I., Doveró, S., Pérez‐Villalba, A., Fernagut, P., Blesa, J., Parent, A., Perier, C., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24066 · Cited by 629 · see citing works
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies
Peng, C., Gathagan, R. J., Covell, D. J., Medellin, C., Stieber, A., Robinson, J. L., Zhang, B., Pitkin, R. M., Olufemi, M. F., Luk, K. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0104-4 · Cited by 605 · see citing works
El-Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Cooper, L. J., Fullwood, N. J., Gibson, M. J., Curran, M. D., Court, J. A., Mann, D. M. A., Ikeda, S.-I., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0098fje · Cited by 590 · see citing works
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583 · see citing works
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150642 · Cited by 579 · see citing works
A Broken α-Helix in Folded α-Synuclein
Chandra, S. S., Chen, X., Rizo, J., Jahn, R., & Südhof, T. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213128200 · Cited by 540 · see citing works
Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P. J., Pöyhönen, M., & Paetau, A. E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.024 · Cited by 535 · see citing works
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528 · see citing works
Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K. (2020) · Brain · doi:10.1093/brain/awaa090 · Cited by 522 · see citing works
Uversky, V. N. (2003) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2003.10506918 · Cited by 502 · see citing works
Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., & Langen, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807826105 · Cited by 501 · see citing works
Shahnawaz, M., Tokuda, T., Waragai, M., Méndez, N., Ishii, R., Trenkwalder, C., Mollenhauer, B., & Soto, C. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4547 · Cited by 485 · see citing works
Burré, J., Sharma, M., & Südhof, T. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416598111 · Cited by 478 · see citing works
Chen, S. W., Drakulić, S., Deas, E., Ouberai, M. M., Aprile, F. A., Arranz, R., Ness, S., Roodveldt, C., Guilliams, T., Genst, E. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421204112 · Cited by 471 · see citing works
Assembly-dependent endocytosis and clearance of extracellular a-synuclein
Lee, H.-J., Suk, J.-E., Bae, E.-J., Lee, J.-H., Paik, S. R., & Lee, S.-J. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.01.017 · Cited by 470 · see citing works
Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease
Shannon, K. M., Keshavarzian, A., Mutlu, E., Dodiya, H. B., Daian, D., Jaglin, J. A., & Kordower, J. H. (2012) · Movement Disorders · doi:10.1002/mds.23838 · Cited by 469 · see citing works
A novel α-synuclein missense mutation in Parkinson disease
Proukakis, C., Dudzik, C. G., Brier, T., Mackay, D. S., Cooper, J. A. D., Millhauser, G. L., Houlden, H., & Schapira, A. H. V. (2013) · Neurology · doi:10.1212/wnl.0b013e31828727ba · Cited by 465 · see citing works
Kiely, A. P., Asi, Y. T., Kara, E., Limousin, P. D., Ling, H., Lewis, P. A., Proukakis, C., Quinn, N. P., Lees, A. J., Hardy, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1096-7 · Cited by 450 · see citing works
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0238-6 · Cited by 450 · see citing works
Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study
Liu, B., Fang, F., Pedersen, N. L., Tillander, A., Ludvigsson, J. F., Ekbom, A., Svenningsson, P., Chen, H., & Wirdefeldt, K. (2017) · Neurology · doi:10.1212/wnl.0000000000003961 · Cited by 447 · see citing works
Mendez, I. M., Viñuela, Á., Astradsson, A., Mukhida, K., Hallett, P. J., Robertson, H. A., Tierney, T. S., Holness, R. O., Dagher, A., Trojanowski, J. Q., et al. (2008) · Nature Medicine · doi:10.1038/nm1752 · Cited by 442 · see citing works
Intrinsically disordered proteins from A to Z
Uversky, V. N. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.04.001 · Cited by 434 · see citing works
Olfaction in Parkinson's disease and related disorders
Doty, R. L. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.026 · Cited by 431 · see citing works
Medical records documentation of constipation preceding Parkinson disease
Savica, R., Carlin, J. M., Grossardt, B. R., Bower, J. H., Ahlskog, J. E., Maraganore, D. M., Bharucha, A. E., & Rocca, W. A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34af5 · Cited by 431 · see citing works
Stuendl, A., Kunadt, M., Kruse, N., Bartels, C., Moebius, W., Danzer, K. M., Mollenhauer, B., & Schneider, A. (2016) · Brain · doi:10.1093/brain/awv346 · Cited by 428 · see citing works
Neuropathology underlying clinical variability in patients with synucleinopathies
Halliday, G. M., Holton, J. L., Révész, T., & Dickson, D. W. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0852-9 · Cited by 426 · see citing works
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
Mittal, S., Bjørnevik, K., Im, D. S., Flierl, A., Dong, X., Locascio, J. J., Abo, K. M., Long, E., Jin, M., Xu, B. Y., et al. (2017) · Science · doi:10.1126/science.aaf3934 · Cited by 417 · see citing works
Stokholm, M. G., Danielsen, E. H., Hamilton‐Dutoit, S. J., & Borghammer, P. (2016) · Annals of Neurology · doi:10.1002/ana.24648 · Cited by 415 · see citing works
Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes
Abounit, S., Bousset, L., Loria, F., Zhu, S., de Chaumont, F., Pieri, L., Olivo‐Marin, J., Melki, R., & Zurzolo, C. (2016) · The EMBO Journal · doi:10.15252/embj.201593411 · Cited by 414 · see citing works
Human Hsp70 Disaggregase Reverses Parkinson’s-Linked α-Synuclein Amyloid Fibrils
Gao, X., Carroni, M., Nussbaum-Krammer, C. I., Mogk, A., Nillegoda, N. B., Szlachcic, A., Guilbride, D. L., Saibil, H. R., Mayer, M. P., & Bukau, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.012 · Cited by 404 · see citing works
Review: Sporadic Parkinson's disease: development and distribution ofα‐synuclein pathology
Tredici, K. D., & Braak, H. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 396 · see citing works
Rey, N. L., Steiner, J. A., Maroof, N., Luk, K. C., Madaj, Z., Trojanowski, J. Q., Lee, V. M. ‐., & Brundin, P. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160368 · Cited by 389 · see citing works
Mollenhauer, B., Cullen, V., Kahn, I., Krastins, B., Outeiro, T. F., Pepivani, I., Ng, J., Schulz-Schaeffer, W., Kretzschmar, H. A., McLean, P. J., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.004 · Cited by 382 · see citing works
Self-citationA critical evaluation of the Braak staging scheme for Parkinson's disease
Burke, R. E., Dauer, W. T., & Vonsattel, J. P. (2008) · Annals of Neurology · doi:10.1002/ana.21541 · Cited by 377 · see citing works
Neuron‐to‐neuron transmission of α‐synuclein fibrils through axonal transport
Freundt, E. C., Maynard, N., Clancy, E. K., Roy, S., Bousset, L., Sourigues, Y., Covert, M. W., Melki, R., Kirkegaard, K., & Brahic, M. (2012) · Annals of Neurology · doi:10.1002/ana.23747 · Cited by 370 · see citing works
McCann, H., Stevens, C. H., Cartwright, H., & Halliday, G. M. (2014) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70017-8 · Cited by 364 · see citing works
El‐Agnaf, O. M. A., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01418-5 · Cited by 363 · see citing works
Accumulation of Phosphorylated α-Synuclein in Aging Human Brain
Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 351 · see citing works
Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
Rostami, J., Holmqvist, S., Lindström, V., Sigvardson, J., Westermark, G. T., Ingelsson, M., Bergström, J., Roybon, L., & Erlandsson, A. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0983-17.2017 · Cited by 339 · see citing works
Research in motion: the enigma of Parkinson's disease pathology spread
Brundin, P., Li, J., Holton, J. L., Lindvall, O., & Révész, T. (2008) · Nature reviews. Neuroscience · doi:10.1038/nrn2477 · Cited by 328 · see citing works
Uemura, N., Yagi, H., Uemura, M. T., Hatanaka, Y., Yamakado, H., & Takahashi, R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0257-5 · Cited by 328 · see citing works
α-Synuclein strains target distinct brain regions and cell types
Lau, A., So, R. W. L., Lau, H. H. C., Sang, J. C., Ruiz‐Riquelme, A., Fleck, S. C., Stuart, E., Menon, S. A., Visanji, N. P., Meisl, G., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0541-x · Cited by 312 · see citing works
Prions, prionoids and protein misfolding disorders
Scheckel, C., & Aguzzi, A. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0011-4 · Cited by 308 · see citing works
Parkinson's Disease: The Dual Hit Theory Revisited
Hawkes, C. H., Del Tredici, K., & Braak, H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04365.x · Cited by 303 · see citing works
Van Den Berge, N., Ferreira, N., Gram, H., Mikkelsen, T. W., Alstrup, A. K. O., Casadei, N., Tsung-Pin, P., Riess, O., Nyengaard, J. R., Tamgüney, G., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02040-w · Cited by 300 · see citing works
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
Walsh, D. M., & Selkoe, D. J. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.13 · Cited by 290 · see citing works
Polinski, N. K., Volpicelli-Daley, L. A., Sortwell, C. E., Luk, K. C., Cremades, N., Gottler, L. M., Froula, J., Duffy, M. F., Lee, V. M. Y., Martinez, T. N., et al. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-171248 · Cited by 288 · see citing works
Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 282 · see citing works
Jang, A., Lee, H., Suk, J., Jung, J., Kim, K., & Lee, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06695.x · Cited by 281 · see citing works
Alpha‐synuclein transfers from neurons to oligodendrocytes
Reyes, J. F., Rey, N. L., Bousset, L., Melki, R., Brundin, P., & Angot, É. (2013) · Glia · doi:10.1002/glia.22611 · Cited by 278 · see citing works
The prion hypothesis in Parkinson's disease: braak to the future
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-2 · Cited by 278 · see citing works
Loría, F., Vargas, J., Bousset, L., Syan, S., Salles, A., Melki, R., & Zurzolo, C. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1746-2 · Cited by 278 · see citing works
Prying into the Prion Hypothesis for Parkinson's Disease
Brundin, P., & Melki, R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1788-16.2017 · Cited by 274 · see citing works
The vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N. L., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 274 · see citing works
Minakaki, G., Menges, S., Kittel, A., Emmanouilidou, E., Schaeffner, I., Barkovits, K., Bergmann, A., Rockenstein, E., Adame, A., Marxreiter, F., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1395992 · Cited by 272 · see citing works
Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo
Angot, E., Steiner, J. A., Lema Tomé, C. M., Ekström, P., Mattsson, B., Björklund, A., & Brundin, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039465 · Cited by 270 · see citing works
α-Synuclein promotes dilation of the exocytotic fusion pore
Logan, T., Bendor, J., Toupin, C., Thorn, K., & Edwards, R. H. (2017) · Nature Neuroscience · doi:10.1038/nn.4529 · Cited by 267 · see citing works
Caudo‐rostral brain spreading of α‐synuclein through vagal connections
Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250 · see citing works
Bassil, F., Brown, H. J., Pattabhiraman, S., Iwasyk, J. E., Maghames, C. M., Meymand, E. S., Cox, T. O., Riddle, D. M., Zhang, B., Trojanowski, J. Q., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.10.010 · Cited by 243 · see citing works
Fares, M.-B., Ait‐Bouziad, N., Dikiy, I., Mbefo, M. K., Jovi, A., Kiely, A. P., Holton, J. L., Lee, S., Gitler, A. D., Eliezer, D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu165 · Cited by 241 · see citing works
Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders
Beach, T. G., White, C. L., Hladik, C. L., Sabbagh, M. N., Connor, D. J., Shill, H. A., Sue, L. I., Sasse, J., Bachalakuri, J., Henry-Watson, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0450-7 · Cited by 236 · see citing works
Volpicelli‐Daley, L. A., Gamble, K. L., Schultheiss, C. E., Riddle, D. M., West, A. B., & Lee, V. M. ‐. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-02-0741 · Cited by 233 · see citing works
Jo, E., Fuller, N., Rand, R. P., George‐Hyslop, P. S., & Fraser, P. E. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5269 · Cited by 231 · see citing works
Neuropathological basis of nonmotor manifestations of Parkinson's disease
Adler, C. H., & Beach, T. G. (2016) · Movement Disorders · doi:10.1002/mds.26605 · Cited by 230 · see citing works
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Jellinger, K. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.006 · Cited by 229 · see citing works
Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
Devic, I., Hwang, H., Edgar, J. S., Izutsu, K. T., Presland, R. B., Pan, C., Goodlett, D. R., Wang, Y., Armaly, J., Tumas, V., et al. (2011) · Brain · doi:10.1093/brain/awr015 · Cited by 222 · see citing works
Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome
Emmanouilidou, E., Stefanis, L., & Vekrellis, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.008 · Cited by 221 · see citing works
Lee, J., Takahama, S., Zhang, G., Tomarev, S. I., & Ye, Y. (2016) · Nature Cell Biology · doi:10.1038/ncb3372 · Cited by 217 · see citing works
Rey, N. L., George, S., Steiner, J. A., Madaj, Z., Luk, K. C., Trojanowski, J. Q., Lee, V. M.-Y., & Brundin, P. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1792-9 · Cited by 215 · see citing works
Nigral pathology and parkinsonian signs in elders without Parkinson disease
Buchman, A. S., Shulman, J. M., Nag, S., Leurgans, S. E., Arnold, S. E., Morris, M. C., Schneider, J. A., & Bennett, D. A. (2011) · Annals of Neurology · doi:10.1002/ana.22588 · Cited by 213 · see citing works
Parkinson’s disease and multiple system atrophy have distinct α-synuclein seed characteristics
Yamasaki, T. R., Holmes, B. B., Furman, J. L., Dhavale, D. D., Su, B. W., Song, E.-S., Cairns, N. J., Kotzbauer, P. T., & Diamond, M. I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004471 · Cited by 212 · see citing works
Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
Pletniková, O., West, N. C., Lee, M. K., Rudow, G. L., Skolasky, R. L., Dawson, T. M., Marsh, L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.006 · Cited by 209 · see citing works
α‐synuclein assemblies sequester neuronal α3‐Na+/K+‐ATPase and impair Na+ gradient
Shrivastava, A. N., Redeker, V., Fritz, N., Pieri, L., Almeida, L. G., Spolidoro, M., Liebmann, T., Bousset, L., Renner, M. L., Léna, C., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591397 · Cited by 206 · see citing works
Definition of a Molecular Pathway Mediating α-Synuclein Neurotoxicity
Burré, J., Sharma, M., & Südhof, T. C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4650-14.2015 · Cited by 202 · see citing works
Functional cooperation of α-synuclein and VAMP2 in synaptic vesicle recycling
Sun, J., Wang, L., Bao, H., Premi, S., Das, U., Chapman, E. R., & Roy, S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903049116 · Cited by 202 · see citing works
Scrapie Produced Experimentally in Goats With Special Reference To the Clinical Syndrome
Pattison, I. H., & Millson, G. C. (1961) · Journal of Comparative Pathology and Therapeutics · doi:10.1016/s0368-1742(61)80013-1 · Cited by 201 · see citing works
Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein
Sung, J. Y., Kim, J., Paik, S. R., Park, J. H., Ahn, Y. S., & Chung, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101318200 · Cited by 200 · see citing works
Manfredsson, F. P., Luk, K. C., Benskey, M. J., Gezer, A., Garcia, J., Kuhn, N. C., Sandoval, I. M., Patterson, J. R., O'Mara, A., Yonkers, R., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.008 · Cited by 199 · see citing works
Prions and Neurodegenerative Diseases
Epstein, F. H., & Prusiner, S. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712173172505 · Cited by 192 · see citing works
Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
Luk, K. C., Covell, D. J., Kehm, V. M., Zhang, B., Song, I. Y., Byrne, M. D., Pitkin, R. M., Decker, S. C., Trojanowski, J. Q., & Lee, V. M.-Y. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.053 · Cited by 191 · see citing works
Parkinson's Disease Is Not Simply a Prion Disorder
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 186 · see citing works
The concept of alpha-synuclein as a prion-like protein: ten years after
Steiner, J. A., Quansah, E., & Brundin, P. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2814-1 · Cited by 183 · see citing works
Pathology associated with sporadic Parkinson’s disease — where does it end?
Braak, H., Müller, C. M., Rüb, U., Ackermann, H., Bratzke, H., de Vos, R. A. I., & Tredici, K. D. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_15 · Cited by 182 · see citing works
Kellie, J. F., Higgs, R. E., Ryder, J. W., Major, A., Beach, T. G., Adler, C. H., Merchant, K., & Knierman, M. D. (2014) · Scientific Reports · doi:10.1038/srep05797 · Cited by 182 · see citing works
Burré, J., Sharma, M., & Südhof, T. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3545-12.2012 · Cited by 175 · see citing works
Role of α‐synuclein penetration into the membrane in the mechanisms of oligomer pore formation
Tsigelny, I. F., Sharikov, Y., Wrasidlo, W., Gonzalez, T., Desplats, P., Crews, L. A., Spencer, B. J., & Masliah, E. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08489.x · Cited by 170 · see citing works
Irwin, D. J., Abrams, J. Y., Schonberger, L. B., Leschek, E., Mills, J. L., Lee, V. M. ‐., & Trojanowski, J. Q. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1933 · Cited by 167 · see citing works
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
Peng, C., Gathagan, R. J., & Lee, V. M. ‐. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.018 · Cited by 164 · see citing works
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease
Milber, J. M., Noorigian, J. V., Morley, J. F., Petrovitch, H., White, L., Ross, G. W., & Duda, J. E. (2012) · Neurology · doi:10.1212/wnl.0b013e318278fe32 · Cited by 163 · see citing works
Bernis, M. E., Babila, J. T., Breid, S., Wüsten, K. A., Wüllner, U., & Tamgüney, G. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0254-7 · Cited by 163 · see citing works
Structural and Functional Implications of C-Terminal Regions of α-Synuclein
Kim, T. D., Paik, S. R., & Yang, C. (2002) · Biochemistry · doi:10.1021/bi026284c · Cited by 162 · see citing works
Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1
Brahic, M., Bousset, L., Bieri, G., Melki, R., & Gitler, A. D. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1538-0 · Cited by 162 · see citing works
Starke Belege: Parkinson könnte im Verdauungstrakt beginnen
(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-113319 · Cited by 162 · see citing works
Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy
Fussi, N., Höllerhage, M., Chakroun, T., Nykänen, N.-P., Rösler, T. W., Koeglsperger, T., Wurst, W., Behrends, C., & Höglinger, G. U. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0816-2 · Cited by 161 · see citing works
Ghosh, D., Sahay, S., Ranjan, P., Salot, S., Mohite, G. M., Singh, P. K., Dwivedi, S., Carvalho, E. J., Banerjee, R., Kumar, A., et al. (2014) · Biochemistry · doi:10.1021/bi5010365 · Cited by 158 · see citing works
Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
Badiola, N., de Oliveira, R. M., Herrera, F., Guardia‐Laguarta, C., Gonçalves, S. A., Pera, M., Suárez‐Calvet, M., Clarimón, J., Outeiro, T. F., & Lleó, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026609 · Cited by 150 · see citing works
Self-citationWang, X., Yu, S., Li, F., & Feng, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.030 · Cited by 148 · see citing works
Melki, R. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150543 · Cited by 147 · see citing works
Structural and functional properties of prefibrillar α-synuclein oligomers
Pieri, L., Madiona, K., & Melki, R. (2016) · Scientific Reports · doi:10.1038/srep24526 · Cited by 145 · see citing works
Cell Biology of Prions and Prionoids: A Status Report
Aguzzi, A., & Lakkaraju, A. K. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.08.007 · Cited by 142 · see citing works
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
Lee, H.-J., Baek, S. M., Ho, D. H., Suk, J., Cho, E.-D., & Lee, S. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.4.026 · Cited by 137 · see citing works
Ihse, E., Yamakado, H., van Wijk, X. M., Lawrence, R., Esko, J. D., & Masliah, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-08720-5 · Cited by 137 · see citing works
Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
Froula, J. M., Castellana-Cruz, M., Anabtawi, N. M., Camino, J. D., Chen, S. W., Thrasher, D. R., Freire, J., Yazdi, A. A., Fleming, S., Dobson, C. M., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007743 · Cited by 129 · see citing works
Bae, E.-J., Ho, D. H., Park, E., Jung, J. W., Cho, K., Hong, J. H., Lee, H.-J., Kim, K. P., & Lee, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4429 · Cited by 126 · see citing works
Amino acid sequence motifs and mechanistic features of the membrane translocation of α‐synuclein
Ahn, K. J., Paik, S. R., Chung, K. C., & Kim, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03731.x · Cited by 123 · see citing works
Peelaerts, W., Bousset, L., Baekelandt, V., & Melki, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2839-5 · Cited by 121 · see citing works
Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
Vasili, E., Dominguez‐Meijide, A., & Outeiro, T. F. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00107 · Cited by 117 · see citing works
Self-citationG2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Gaig, C., Martı́, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., & TOLOSA, E. S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107904 · Cited by 113 · see citing works
DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins
Xu, Y., Cui, L., DiBello, A., Wang, L., Lee, J., Saidi, L. F., Lee, J., & Ye, Y. (2018) · Cell Discovery · doi:10.1038/s41421-018-0012-7 · Cited by 113 · see citing works
Olanow, C. W., Savolainen, M., Chu, Y., Halliday, G. M., & Kordower, J. H. (2019) · Brain · doi:10.1093/brain/awz104 · Cited by 112 · see citing works
Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes
Chu, Y., Muller, S., Tavares, A., Barret, O., Alagille, D., Seibyl, J. P., Tamagnan, G. D., MAREK, K. L., Luk, K. C., Trojanowski, J. Q., et al. (2019) · Brain · doi:10.1093/brain/awz296 · Cited by 112 · see citing works
New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy
Guerrero-Ferreira, R., Kováčik, Ľ., Ni, D., & Stahlberg, H. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.014 · Cited by 108 · see citing works
The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease
Vargas, J., Grudina, C., & Zurzolo, C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.012 · Cited by 106 · see citing works
Helwig, M., Klinkenberg, M., Rusconi, R., Musgrove, R. E., Majbour, N. K., El‐Agnaf, O. M. A., Ulusoy, A., & Monte, D. A. D. (2015) · Brain · doi:10.1093/brain/awv376 · Cited by 96 · see citing works
MSA prions exhibit remarkable stability and resistance to inactivation
Woerman, A. L., Kazmi, S. A., Patel, S. S., Freyman, Y., Oehler, A., Aoyagi, A., Mordes, D. A., Halliday, G. M., Middleton, L. T., Gentleman, S., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1762-2 · Cited by 95 · see citing works
Simonsen, A. H., Kuiperij, H. B., El‐Agnaf, O. M. A., Engelborghs, S., Herukka, S., Parnetti, L., Rektorová, I., Vanmechelen, E., Kapaki, E. N., Verbeek, M. M., et al. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.105 · Cited by 94 · see citing works
DeWitt, D. C., & Rhoades, E. R. (2013) · Biochemistry · doi:10.1021/bi4002369 · Cited by 93 · see citing works
Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury
Ulusoy, A., Musgrove, R. E., Rusconi, R., Klinkenberg, M., Helwig, M., Schneider, A., & Monte, D. A. D. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0198-y · Cited by 92 · see citing works
Woerman, A. L., Oehler, A., Kazmi, S. A., Lee, J., Halliday, G. M., Middleton, L. T., Gentleman, S., Mordes, D. A., Spina, S., Grinberg, L. T., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01959-4 · Cited by 88 · see citing works
A cell culture model for monitoring α-synuclein cell-to-cell transfer
Reyes, J. F., Olsson, T. T., Lamberts, J. T., Devine, M. J., Kunath, T., & Brundin, P. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.003 · Cited by 84 · see citing works
Uemura, N., Uemura, M. T., Lo, A., Bassil, F., Zhang, B., Luk, K. C., Lee, V. M. ‐., Takahashi, R., & Trojanowski, J. Q. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz070 · Cited by 82 · see citing works
The Contribution of α -Synuclein Spreading to Parkinson’s Disease Synaptopathy
Longhena, F., Faustini, G., Missale, C., Pizzi, M., Spano, P., & Bellucci, A. (2017) · Neural Plasticity · doi:10.1155/2017/5012129 · Cited by 81 · see citing works
Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau
Hudák, A., Kúsz, E., Domonkos, I., Jósvay, K., Kodamullil, A. T., Szilák, L., Hofmann‐Apitius, M., & Letoha, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-53038-z · Cited by 81 · see citing works
Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are α-synucleinopathies
Spillantini, M. G. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00031-0 · Cited by 80 · see citing works
Courte, J., Bousset, L., von Boxberg, Y., Villard, C., Melki, R., & Peyrin, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61757-x · Cited by 80 · see citing works
Sorrentino, Z. A., Brooks, M. M. T., Hudson, V., Rutherford, N. J., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0182-z · Cited by 79 · see citing works
Zhang, S., Eitan, E., Wu, T.-Y., & Mattson, M. P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.016 · Cited by 76 · see citing works
Reyes, J. F., Sackmann, C., Hoffmann, A., Svenningsson, P., Winkler, J., Ingelsson, M., & Hallbeck, M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02007-x · Cited by 74 · see citing works
Mechanisms of alpha-synuclein toxicity: An update and outlook
Brás, I. C., Xylaki, M., & Outeiro, T. F. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.005 · Cited by 73 · see citing works
Self-citation14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein
Wang, B., Underwood, R., Kamath, A., Britain, C. M., McFerrin, M. B., McLean, P. J., Volpicelli‐Daley, L. A., Whitaker, R. H., Placzek, W. J., Becker, K., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1134-18.2018 · Cited by 70 · see citing works
Díaz, E. F., Labra, V. C., Alvear, T. F., Mellado, L. A., Inostroza, C. A., Oyarzún, J. E., Salgado, N., Quintanilla, R. A., & Orellana, J. A. (2019) · Glia · doi:10.1002/glia.23631 · Cited by 63 · see citing works
Hsp110 mitigates α-synuclein pathology in vivo
Taguchi, Y. V., Gorenberg, E. L., Nagy, M., Thrasher, D. R., Fenton, W. A., Volpicelli‐Daley, L. A., Horwich, A. L., & Chandra, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903268116 · Cited by 60 · see citing works
Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
Gegg, M. E., Verona, G., & Schapira, A. H. V. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa085 · Cited by 58 · see citing works
Johansen, K. K., TORP, S. H., Farrer, M. J., Gustavsson, E. K., & Aasly, J. O. (2018) · Case Reports in Neurological Medicine · doi:10.1155/2018/6838965 · Cited by 54 · see citing works
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
Guan, Y., Zhao, X., Liu, F., Yan, S., Wang, Y., Du, C., Cui, X., Li, R., & Zhang, C. X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00159 · Cited by 54 · see citing works
Tomás‐Zapico, C., Diez-Zaera, M., Ferrer, I., Gómez‐Ramos, P., Morán, M. A., Miras‐Portugal, M. T., Dı́az-Hernández, M., & Lucas, J. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr507 · Cited by 50 · see citing works
McKinnon, J. H., Evidente, V. G. H., Driver‐Dunckley, E. D., Premkumar, A. P., Hentz, J. G., Shill, H. A., Sabbagh, M., Caviness, J. N., Connor, D. J., & Adler, C. H. (2010) · International Journal of Neuroscience · doi:10.3109/00207450903428954 · Cited by 44 · see citing works
A critical review of the prion hypothesis of human synucleinopathies
Tamgüney, G., & Korczyn, A. D. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2712-y · Cited by 42 · see citing works
Llorens, F., Schmitz, M., Varges, D., Kruse, N., Gotzmann, N., Gmitterová, K., Mollenhauer, B., & Zerr, I. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8259-0 · Cited by 41 · see citing works
Alpha-synuclein fragments trigger distinct aggregation pathways
Chakroun, T., Evsyukov, V., Nykänen, N.-P., Höllerhage, M., Schmidt, A., Kamp, F., Ruf, V., Wurst, W., Rösler, T. W., & Höglinger, G. U. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2285-7 · Cited by 41 · see citing works
Abundant glial α-synuclein pathology in a case without overt clinical symptoms
Parkkinen, L., Hartikainen, P. H., & Alafuzoff, I. I. (2007) · Clinical Neuropathology · doi:10.5414/npp26276 · Cited by 39 · see citing works
Uemura, N., Yagi, H., Uemura, M. T., Yamakado, H., & Takahashi, R. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134651 · Cited by 37 · see citing works
Flagged first, then by citations
1 of the 209 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · see citing works
Vidović, M., & Rikalović, M. (2022) · Cells · doi:10.3390/cells11111732 · Cited by 210 · see citing works
Magalhães, P., & Lashuel, H. A. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00357-0 · Cited by 157 · see citing works
McGarry, A., Rosanbalm, S., Leinonen, M., Olanow, C. W., To, D., Bell, A., Lee, D., Chang, J., Dubow, J., Dhall, R., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00378-2 · Cited by 153 · see citing works
O-GlcNAcylation in health and neurodegenerative diseases
Lee, B. E., Suh, P., & Kim, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00709-5 · Cited by 143 · see citing works
Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside
Mishra, A., Bandopadhyay, R., Singh, P. K., Mishra, P. S., Sharma, N., & Khurana, N. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00806-4 · Cited by 132 · see citing works
Lv, Q.-K., Tao, K., Wang, X.-B., Yao, X., Pang, M., Liu, J., Wang, F., & Liu, C. (2023) · Inflammation Research · doi:10.1007/s00011-022-01676-x · Cited by 108 · see citing works
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Menon, S. A., Armstrong, S. E. M., Hamzeh, A. M., Visanji, N. P., Sardi, S. P., & Tandon, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.852003 · Cited by 107 · see citing works
Wang, Y., Gao, L., Chen, J., Li, Q., Huo, L., Wang, Y., Wang, H., & Du, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.757161 · Cited by 106 · see citing works
Toader, C., Tătaru, C. P., Munteanu, O., Șerban, M., Covache-Busuioc, R.-A., Ciurea, A. V., & Enyedi, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312613 · Cited by 105 · see citing works
Kuo, M., Liu, S. C.-H., Hsu, Y.-F., & Wu, R. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00775-x · Cited by 96 · see citing works
Role of Ubiquitin–Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance
Sahoo, S., Padhy, A. A., Kumari, V., & Mishra, P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02897-1 · Cited by 82 · see citing works
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Deyell, J., Sriparna, M., Ying, M., & Mao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032477 · Cited by 70 · see citing works
Alpha-Synuclein and Lipids: The Elephant in the Room?
Sarchione, A., Marchand, A., Taymans, J., & Chartier‐Harlin, M. (2021) · Cells · doi:10.3390/cells10092452 · Cited by 67 · see citing works
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Neupane, S., Cecco, E. D., & Aguzzi, A. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167930 · Cited by 66 · see citing works
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63 · see citing works
Cognitive heterogeneity in Parkinson’s disease: A mechanistic view
Carceles‐Cordon, M., Weintraub, D., & Chen‐Plotkin, A. S. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.021 · Cited by 58 · see citing works
Kuo, G., Kumbhar, R., Blair, W., Dawson, V. L., Dawson, T. M., & Mao, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00797-1 · Cited by 52 · see citing works
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Eo, H., Kim, S., Jung, U. J., & Kim, S. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237243 · Cited by 47 · see citing works
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges
Arias-Carrión, Ó., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., & Manjarrez, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115405 · Cited by 50 · see citing works
Morales-Martínez, A., Martínez-Gómez, P. A., Martínez‐Fong, D., Villegas-Rojas, M. M., Pérez‐Severiano, F., Toro-Colín, M. A. D., Delgado-Minjares, K. M., Blanco-Álvarez, V. M., León‐Chávez, B. A., Aparicio‐Trejo, O. E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911394 · Cited by 42 · see citing works
Miao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 37 · see citing works
Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreading
Helwig, M., Ulusoy, A., Rollar, A., O’Sullivan, S. A., Lee, S. S. L., Aboutalebi, H., Pinto‐Costa, R., Jevans, B., Klinkenberg, M., & Monte, D. A. D. (2022) · Science Advances · doi:10.1126/sciadv.abn0356 · Cited by 36 · see citing works
Venezia, S., Kaufmann, W. A., Wenning, G. K., & Stefanova, N. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.09.007 · Cited by 31 · see citing works
Disease modification in Parkinsonism: obstacles and ways forward
Höllerhage, M., Klietz, M., & Höglinger, G. U. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02520-6 · Cited by 29 · see citing works
Siwecka, N., Saramowicz, K., Galita, G., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082051 · Cited by 31 · see citing works
A same day α-synuclein RT-QuIC seed amplification assay for synucleinopathy biospecimens
Parveen, S., Alam, P., Orru, C. D., Vascellari, S., Hughson, A. G., Zou, W., Beach, T. G., Serrano, G. E., Goldstein, D. S., Ghetti, B. F., et al. (2025) · npj Biosensing · doi:10.1038/s44328-024-00023-w · Cited by 31 · see citing works
Hsu, Y.-L., Hung, H., Tsai, C.-W., Liu, S., Chiang, Y.-T., Kuo, Y.-H., Shyu, W., Lin, S., & Fu, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910240 · Cited by 29 · see citing works
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
Sidoroff, V., Bower, P., Stefanova, N., Fanciulli, A., Stankovic, I., Poewe, W. H., Seppi, K., Wenning, G. K., & Krismer, F. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223183 · Cited by 24 · see citing works
Ishiguro, Y., Tsunemi, T., Shimada, T., Yoroisaka, A., Ueno, S., Takeshige‐Amano, H., Hatano, T., Inoue, Y., Saiki, S., & Hattori, N. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149620 · Cited by 22 · see citing works
Small Molecule Fisetin Modulates Alpha–Synuclein Aggregation
Rosado-Ramos, R., Godinho-Pereira, J., Marques, D., Figueira, I., Outeiro, T. F., Menezes, R., & dos Santos, C. N. (2021) · Molecules · doi:10.3390/molecules26113353 · Cited by 22 · see citing works
Self-citationNuclear imaging in Parkinson's disease: The past, the present, and the future
Golan, H., Volkov, O., & Shalom, E. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120220 · Cited by 20 · see citing works
Drug reprofiling history and potential therapies against Parkinson’s disease
Latif, K., Ullah, A., Shkodina, A. D., Boiko, D. I., Rafique, Z., Alghamdi, B. S. A., Alfaleh, M. A., & Ashraf, G. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1028356 · Cited by 19 · see citing works
The density of anionic lipids modulates the adsorption of α-Synuclein onto lipid membranes
Andersson, A., Linse, S. S., Sparr, E., Fornasier, M., & Jönsson, P. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107143 · Cited by 18 · see citing works
Is Multiple System Atrophy a Prion-like Disorder?
Jellinger, K. A., Wenning, G. K., & Stefanova, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810093 · Cited by 18 · see citing works
Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner
Xiong, M., Xia, D., Yu, H., Meng, L., Zhang, X., Chen, J., Tian, Y., Yuan, X., Niu, X., Nie, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202413451 · Cited by 17 · see citing works
Ayral, V., Pastor‐Bernier, A., Daneault, V., Tremblay, C., Filiatrault, M., Haddad, C., Gagnon, J., Postuma, R. B., Dušek, P., Mareček, S., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214042 · Cited by 16 · see citing works
Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators
Schmitt, V., Masanetz, R. K., Weidenfeller, M., Ebbinghaus, L. S., Süß, P., Rosshart, S. P., von Hörsten, S., Zunke, F., Winkler, J., & Xiang, W. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114574 · Cited by 16 · see citing works
α‐Synuclein Pathology Spreads in a Midbrain–Hindbrain Assembloid Model
Gomez‐Giro, G., Frangenberg, D., Gutiérrez, D. M. V., Žagare, A., Barmpa, K., Antony, P. M. A., Robertson, G., Sabahi‐Kaviani, R., Händler, K., Kruse, N., et al. (2025) · Advanced Science · doi:10.1002/advs.202409040 · Cited by 14 · see citing works
The α-Synuclein Seeding Amplification Assay for Parkinson’s Disease
Yi, L., Tan, E., & Zhou, Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010389 · Cited by 14 · see citing works
Is a cure for Parkinson’s disease hiding inside us?
Santos, J., Pallarès, I., & Ventura, S. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.02.001 · Cited by 14 · see citing works
Modulating α-synuclein propagation and decomposition: Implications in Parkinson's disease therapy
Li, B., Xiao, X., Bi, M., Jiao, Q., Chen, X., Yan, C., Du, X., & Jiang, H. F. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102319 · Cited by 13 · see citing works
Mekala, S., Wu, Y., & Li, Y. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00576g · Cited by 13 · see citing works
Gatzemeier, L. M., Meyer, F., Diederichsen, U., & Outeiro, T. F. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202300649 · Cited by 13 · see citing works
Self-citationBrás, I. C., Khani, M., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223516 · Cited by 11 · see citing works
Self-citationResearch Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson’s Disease Treatment
Kalsoom, I., Wang, Y., Li, B., & Wen, H. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230517163501 · Cited by 12 · see citing works
Raj, A., Banerjee, R., Santhoshkumar, R., Sagar, C., & Datta, I. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03400-0 · Cited by 11 · see citing works
Radwan, N., Khan, E., Ardah, M. T., Kitada, T., & Haque, M. E. (2023) · Nutrients · doi:10.3390/nu16010085 · Cited by 11 · see citing works
Navigating the Neurobiology of Parkinson’s: The Impact and Potential of α-Synuclein
Paulėkas, E., Vanagas, T., Lagunavičius, S., Pajėdienė, E., Petrikonis, K., & Rastenytė, D. (2024) · Biomedicines · doi:10.3390/biomedicines12092121 · Cited by 11 · see citing works
Bashir, B., Vishwas, S., Gupta, G., Paudel, K. R., Dureja, H., Kumar, P., Cho, H., Sugandhi, V. V., Kumbhar, P., Disouza, J., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102693 · Cited by 11 · see citing works
Fassler, M., Benaim, C., & George, J. (2022) · Cells · doi:10.3390/cells11233822 · Cited by 11 · see citing works
Gonçalves, P. B., Palhano, F. L., Cordeiro, Y., & Sodero, A. C. R. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp02261g · Cited by 11 · see citing works
Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy
Bhatia, T. N., Clark, R. N., Needham, P. G., Miner, K. M., Jamenis, A. S., Eckhoff, E. A., Abraham, N., Hu, X., Wipf, P., Luk, K. C., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01114-6 · Cited by 10 · see citing works
Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies
Bhatt, V., Shukla, H., & Tiwari, A. K. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2306109 · Cited by 9 · see citing works
Staerz, S. D., Anamoah, C., & Tepe, J. J. (2024) · iScience · doi:10.1016/j.isci.2024.110166 · Cited by 9 · see citing works
Limanaqi, F., Zecchini, S., Ogno, P., Artusa, V., Fenizia, C., Saulle, I., Vanetti, C., Garziano, M., Strizzi, S., Trabattoni, D., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1421360 · Cited by 9 · see citing works
Lo, C. H., Cheong, L. Y. T., & Zeng, J. (2025) · Nanomaterials · doi:10.3390/nano15100704 · Cited by 10 · see citing works
Banik, S. P., Bagchi, D., Banerjee, P., Chakraborty, S., Bagchi, M., Bose, C., De, D., Saha, S., & Chakraborty, S. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1603364 · Cited by 8 · see citing works
Protein O‐GlcNAcylation in Health and Diseases
Ran, Z., Chen, C., Ou, J., Wu, G., Yang, C., & Liu, X. (2025) · MedComm · doi:10.1002/mco2.70536 · Cited by 8 · see citing works
From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies
Wiseman, J. A., Reddy, K., & Dieriks, B. V. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102640 · Cited by 8 · see citing works
Oligomeropathies, inflammation and prion protein binding
Forloni, G., Vitola, P. L., & Balducci, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.822420 · Cited by 8 · see citing works
Synucleinopathies: Intrinsic and Extrinsic Factors
Lomeli-Lepe, A. K., Castañeda‐Cabral, J. L., & López‐Pérez, S. J. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01154-z · Cited by 6 · see citing works
Brás, I. C., Khani, M., Vasili, E., Möbius, W., Riedel, D., Parfentev, I., Gerhardt, E., Fahlbusch, C., Urlaub, H., Zweckstetter, M., et al. (2021) · bioRxiv · doi:10.1101/2021.07.18.452825 · Cited by 3 · see citing works
Self-citationTaha, H. B., Kearney, B., & Bitan, G. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1001382 · Cited by 6 · see citing works
Hallbeck, M., Ekmark‐Lewén, S., Kahle, P. J., Ingelsson, M., & Reyes, J. F. (2024) · iScience · doi:10.1016/j.isci.2024.111448 · Cited by 6 · see citing works
Structural Specificity of Polymorphic Forms of α-Synuclein Amyloid
Roterman, I., Stąpor, K., & Konieczny, L. (2023) · Biomedicines · doi:10.3390/biomedicines11051324 · Cited by 6 · see citing works
Elezz, A. M. A., khalefa, K. A., Gadelmawla, A. F., Khattab, Y. A., & Zeid, M. A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01873-0 · Cited by 6 · see citing works
Quantifying motor–cognitive reserve using a novel multi-modal stress test
Kozlovski, T., Maidan, I., Gazit, E., Droby, A., Thaler, A., Hausdorff, J. M., Giladi, N., Benjamini, Y., & Mirelman, A. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf412 · Cited by 5 · see citing works
Galanou, O.-N., & Konstandi, M. (2025) · Biomedicines · doi:10.3390/biomedicines13112813 · Cited by 4 · see citing works
Insights into Dysregulated Neurological Biomarkers in Cancer
Duranti, E., & Villa, C. (2024) · Cancers · doi:10.3390/cancers16152680 · Cited by 6 · see citing works
Path analysis of biomarkers for cognitive decline in early Parkinson’s disease
Gramotnev, D. K., Gramotnev, G., Gramotnev, A., & Summers, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268379 · Cited by 5 · see citing works
Kim, J.-B., Kim, Y., Kim, S., Ha, T., Kim, D., Kim, D. W., So, M. L., Kim, S. H., Woo, H. G., Yoon, D., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03041-7 · Cited by 5 · see citing works
Combining Biomarkers with Genetics In Prodromal/Earliest Phase Parkinson’s Disease
Seibler, P., Streubel-Gallasch, L., & Klein, C. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240155 · Cited by 5 · see citing works
14-3-3θ phosphorylation exacerbates alpha-synuclein aggregation and toxicity
Wang, B., Gannon, M. A., Pattanayak, R., Scholz, K., Pair, F. S., Stone, W. J., Ekkatine, R., Liu, Z., & Yacoubian, T. A. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106801 · Cited by 5 · see citing works
Zeng, N., Wang, Q., Zhang, C., Zhou, Y., & Yan, J. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105610 · Cited by 5 · see citing works
Kunka, A., Farzadfard, A., Larsen, J. A., Saraceno, F., Norrild, R. K., Fricke, C., Mohammad‐Beigi, H., Sadek, A., Folke, J., Aznar, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.01.685997 · Cited by 5 · see citing works
Gatzemeier, L. M., Meyer, F., & Outeiro, T. F. (2024) · ChemBioChem · doi:10.1002/cbic.202400253 · Cited by 4 · see citing works
Self-citationKiersnowski, O. C., Mattioli, P., Argenti, L., Avanzino, L., Calizzano, F., Diociasi, A., Falcitano, L., Liu, C., Losa, M., Massa, F., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-83593-z · Cited by 4 · see citing works
Ross, A., Prowse, N. A., Zhang, H., Hayley, S. P., & Hongyu, S. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1627305 · Cited by 4 · see citing works
Food for thought: probiotic modulation of microglial activity in Parkinson's disease
Kimber, I. K., & Tremblay, M. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1690507 · Cited by 4 · see citing works
Vorobyov, V., Деев, А. Д., Chaprov, K., & Ninkina, N. N. (2024) · Biomedicines · doi:10.3390/biomedicines12040881 · Cited by 4 · see citing works
Bendetowicz, D., Planche, V., Bézard, E., Dehay, B., & Meissner, W. G. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241313443 · Cited by 4 · see citing works
Kotha, S., Sriparna, M., Tyson, J., Li, A., He, W., & Mao, X. (2024) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-49744-5_5 · Cited by 4 · see citing works
dos Santos, L. R., Duplan, E., Debord, J., Fremont, G., Minniti, J., Lauritzen, I., Mutez, E., Leghay, C., Chartier‐Harlin, M., Checler, F., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2669458 · Cited by 3 · see citing works
Brazdis, R.-M., Zoicas, I., Kornhuber, J., & Mühle, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168685 · Cited by 3 · see citing works
Sade, O., Fischel, D., Barak-Broner, N., Halevi, S., Gottfried, I., Bar-On, D., Sachs, S., Mirelman, A., Thaler, A., Gour, A., et al. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1431549 · Cited by 3 · see citing works
Ayral, V., Pastor-Bernier, A., Daneault, V., Tremblay, C., Filiatrault, M., Haddad, C., Gagnon, J., Postuma, R. B., Dušek, P., Marecek, S., et al. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2025.107860 · Cited by 3 · see citing works
Nanni, A. D., Saw, R. S., Bowden, G. D., Bidesi, N., Bjerregaard-Andersen, K., Korat, Š., Herth, M. M., Pichler, B. J., Herfert, K., & Maurer, A. (2023) · Molecules · doi:10.3390/molecules28104001 · Cited by 3 · see citing works
Singh, A., Panhelainen, A. E., & Voutilainen, M. H. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137510 · Cited by 3 · see citing works
Bétemps, D., Arsac, J.-N., Nicot, S., Canal, D., Tlili, H., Bélondrade, M., Morignat, E., Verchère, J., Gaillard, D., Bruyère-Ostells, L., et al. (2023) · Biomolecules · doi:10.3390/biom13121788 · Cited by 2 · see citing works
Bjork, R. T., Patel, F., Daly, M. S., & Miller, J. E. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115698 · Cited by 2 · see citing works
Bidirectional Relationship between the BDNF Gene and miRNA: Implications for PD Pathogenesis
Elangovan, A., Iyer, M., HariKrishnaReddy, D., Wander, A., Kinoshita, M., Krishnan, J., & Vellingiri, B. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00173 · Cited by 3 · see citing works
Aghakhani, N., Arzoo, A., Dorflinger, B. G., Athari, S. Z., & Mohaddes, G. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100297 · Cited by 2 · see citing works
Autophagy–exosome crosstalk in neurodegeneration: Mechanisms and therapeutic opportunities
Sedighi, S., Guan, T., Michetti, F., Cordani, M., Behrooz, A. B., Sabouni, F., Eshraghi, M., Saleem, A., Ghavami, S., & Aghanoori, M. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109025 · Cited by 2 · see citing works
Perspective Strategies for Interventions in Parkinsonism: Remedying the Neglected Role of TPPP
Oláh, J., Norris, V., Lehotzky, A., & Ovádi, J. (2024) · Cells · doi:10.3390/cells13040338 · Cited by 2 · see citing works
The Application of Analytical Techniques to Alpha-Synuclein in Parkinson’s Disease
Olahanmi, O. A. (2024) · American Journal of Analytical Chemistry · doi:10.4236/ajac.2024.159018 · Cited by 2 · see citing works
Decoding Parkinson's disease: A multifaceted approach to diagnosis and biomarker discovery
Ragab, M. H., Soliman, A.-H., Shaltout, A. E.-R., El-Ramly, T. A., Morris, M., Mohamed, O. A. A., Ibrahim, R., & Dakhlaah, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00015-4 · Cited by 2 · see citing works
Baron, T., Arsac, J.-N., Verchère, J., Tlili, H., Aufauvre, C., & Bétemps, D. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02410-x · Cited by 2 · see citing works
Recent updates on immunotherapy in neurodegenerative diseases
Salunkhe, J., & Ugale, R. R. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149205 · Cited by 2 · see citing works
Kondeva-Burdina, M., Panayotova, D., Sharkov, M., Popov, G., Manov, V., Nedialkov, P. T., & Kokanova-Nedialkova, Z. K. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e175172 · Cited by 1 · see citing works
- Authors
- Brás, I. C., & Outeiro, T. F.
- Affiliations
- Universitätsmedizin Göttingen (DE)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Outeiro, Tiago F.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-02-12
- Volume
- 10
- Issue
- 2
- Pages
- 375
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7917664
- OpenAlex
- W3130859323
- Cited by
- 136
- References
- 209
- Citations by year
- 2026: 20 · 2025: 32 · 2024: 32 · 2023: 22 · 2022: 18 · 2021: 12
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DZNE Pub (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (MBExC)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein, synucleinopathies, Parkinson's disease, Lewy body pathology, prion-like spreading, protein misfolding
- MeSH terms
- Synucleinopathies, Brain, Humans, Parkinson Disease, Prions, Disease Progression, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
